A Subcutaneously Administered RNAi Therapeutic (ALN-AT3) Targeting Antithrombin for Treatment of Hemophilia: Interim Phase 1 Study Results in Healthy Volunteers and Patients with Hemophilia a or B
Sorensen, Benny, Mant, Tim, Akinc, Akin, Simon, Amy, Melton, Lauren, Lynam, Christian, Strahs, Andrew, Sehgal, Alfica, Hutabarat, Renta, Chaturvedi, Prasoon, Barros, Scott, Vaishnaw, Akshay, Investigators, Aln-AT
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article